Skip to main content
SpringerLink
Log in

Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue

  • Research Papers
  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

Thirty-eight human pancreatic cancer cases were examined by immunohistochemistry for expression of CA 19-9 and DU-PAN-2 antigens by the respective monoclonal antibodies. CA 19-9 was expressed in 82% and DU-PAN-2 in 87% of cases. A combination of two antibodies increased the reactivity to 97%. Six CA 19-9-negative cases were DU-PAN-2 positive and 4 DU-PAN-2-negative cases expressed CA 19-9. In only 1 case (an anaplastic carcinoma), neither of the antibodies was reactive with cancer cells. The reactivity of tumor cells with each of the antibodies varied from case to case, and, within the same tumor, from one area to another. Histologically, all but one tumor were adenocarcinomas. Thirty-five cases showed areas of either a moderate degree of differentiation (16 cases), poor differentiation (11 cases) or anaplastic areas (8 cases). Although both antigens were expressed in a greater number of cancer cells in well differentiated areas, and less frequently in poorly differentiated and anaplastic regions, the difference in antigen expression in relation to the degree of tumor differentiation was not statistically significant. The cellular localization of the antigens varied. DU-PAN-2 was primarily localized within the cytoplasm, whereas CA 19-9 was found mostly on the luminal cell surface and in luminal content of the glandular structure. In tumor-free pancreatic tissue, adjacent to the tumor, CA 19-9 was detected almost exclusively in the cells of large and medium sized ducts, whereas DU-PAN-2 was primarily expressed in terminal ductular and centrocinar cells. The results indicate that a cocktail of CA 19-9 and DU-PAN-2 antibodies could increase the likelihood of identifying a biomarker in most patients with pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Magnani, J.L., Brockhaus, M., Smith, D.F., Ginsburg, V., Blaszczyk, M., Mitchell, K.F., Steplewski, Z. and Koprowski, H., A monosialo ganglioside is a monoclonal antibody-defined antigen of colon carcinoma, Science, 1981; 212: 55–56.

    Article  PubMed  CAS  Google Scholar 

  2. Magnani, J.L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H. and Ginsburg, V., A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II, J. Biol. Chem., 1982; 257: 14365–14369.

    PubMed  CAS  Google Scholar 

  3. Magnani, J.L., Steplewski, Z., Koprowski, H. and Ginsburg, V., Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin, Cancer Res., 1983; 43: 5489–5492.

    PubMed  CAS  Google Scholar 

  4. Koprowski, H., Brockhaus, M., Blaszczyk, M., Magnani, J., Steplewski, Z. and Ginsburg, V., Lewis blood-type may affect the incidence of gastrointestinal cancer, Lancet, 1982; i: 1332–1333.

    Article  Google Scholar 

  5. Herlyn, M., Sears, H.F., Steplewski, Z. and Koprowski, H., Monoclonal antibody detection of circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma, J. Clin. Immunol., 1982; 2: 135–140.

    Article  PubMed  CAS  Google Scholar 

  6. Del Villano, B.C., Brennan, S., Brock, P., Bucher, C., Liu, V., McClure, M., Rake, B., Space, S., Westrick, B., Schoemaker, H. and Zurawski, V.R., Jr., Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9, Clin. Chem. 1983; 29: 549–552.

    PubMed  Google Scholar 

  7. Ritts, R.E., Jr., Del Villano, B.C., Go, V.L.W., Herberman, R.B., Klug, T.L. and Zurawski, V.R., Jr., Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank, Int. J. Cancer, 1984; 33: 339–345.

    Article  PubMed  Google Scholar 

  8. Satake, K., Kanazawa, G., Kho, I., Chung, Y.S. and Umeyama, K., A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma, J. Surg. Oncol., 1985; 29: 15–21.

    Article  PubMed  CAS  Google Scholar 

  9. Gupta, M.K., Arciaga, R., Bocci, L., Tubbs, R., Bukowski, R. and Deodhar, S.D., Measurement of a monoclonal-antibody-defined antigen (CA 19-9) in the sera of patients with malignant and nonmalignant diseases. Cancer, 1985; 56: 277–283.

    Article  PubMed  CAS  Google Scholar 

  10. Schmiegel, W.H., Kreiker, C., Eberl, W., Arndt, R., Classen, M., Greten, H. Jessen, K., Kalthoff, H., Soehendra, N. and Thiele, H.-G., Monoclonal antibody defines CA 19-9 in pancreatic juices and sera, Gut, 1985; 26: 456–460.

    Article  PubMed  CAS  Google Scholar 

  11. Farini, R., Fabris, G., Bonvicini, P., Piccoli, A., DelFavero, G., Venturini, R., Panucci, A. and Naccarato, R., CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis, Eur. J. Cancer Clin. Oncol., 1985; 21: 429–432.

    Article  PubMed  CAS  Google Scholar 

  12. Schmiegel, W.H., Eberl, W., Kleiker, C., Kalthoff, H., Bützow, G.H., Jessen, K., Klapdor, R., Soehendra, N., Wargenau, M., Classen, M., Greten, H. and Thiele, H.-G., Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases. Hepato-Gastroenterology, 1985; 32: 141–145.

    PubMed  CAS  Google Scholar 

  13. Dietel, M., Arps, H., Klapdor, R., Müller-Hagen, S., Sieck, M. and Hoffmann, L., Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera. J. Cancer Res. Clin. Oncol., 1986; 111: 257–265.

    Article  PubMed  CAS  Google Scholar 

  14. Del Favero, G., Fabris, C., Plebani, M., Panucci, A., Piccoli, A., Parobelli, L., Pedrazzoli, S., Baccaglini, U., Burlina, A. and Naccarato, R., CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis, Cancer 1986; 57: 1576–1579.

    Article  PubMed  Google Scholar 

  15. Lan, M.S., Finn, O.J., Fernsten, P.D. and Metzgar, R.S., Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2, Cancer Res., 1985; 45: 305–310.

    PubMed  CAS  Google Scholar 

  16. Metzgar, R.S., Rodriguez, N., Finn, O.J., Lan, M.S., Daasch, V.N., Fernsten, P.D., Meyers, W.C., Sindelar, W.F., Sandler, R.S. and Siegler, H.F., Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma, Proc. Natl. Acad. Sci. USA; 1984; 81: 5242–5246.

    Article  PubMed  CAS  Google Scholar 

  17. Sawabu, N., Toya, D., Takemori, Y., Hattori, N. and Fukui, M., Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers, Int. J. Cancer, 1986; 37: 693–696.

    Article  PubMed  CAS  Google Scholar 

  18. Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D. and Fuhrer, P., Colorectal carcinoma antigens detected by hybridoma antibodies, Somat. Cell Genet., 1979; 5: 957–972.

    Article  PubMed  CAS  Google Scholar 

  19. Metzgar, R.S., Gaillard, M.T., Levine, S.J., Tuck, F.L., Bossen, E.H. and Borowitz, M.J., Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies, Cancer Res., 1982; 42: 601–608.

    PubMed  CAS  Google Scholar 

  20. Sears, H.F., Herlyn, M., Del Villano, B., Steplewski, Z. and Koprowski, H., Monoclonal antibody detection of a circulating tumor associated antigen. II. A longitudinal evaluation of patients with colorectal cancer, J. Clin. Immunol., 1982; 2: 141–149.

    Article  PubMed  CAS  Google Scholar 

  21. Lorenz, M., Happ, J., Baum, R.P., Hottenrott C., Maul, F.D., Encke, A. and Hör, G., Comparison of CA 19-9 and CEA in the diagnosis of primary tumors and relapse. In: H. Greten and R. Klapdor (Eds), New tumor associated antigens, Georg Thieme Verlag, Stuttgart, 1986; 69–74.

    Google Scholar 

  22. Lorenz, M., Happ, J., Hottenrot, C., Maul, F.D., Baum, R.P., Hör, G. and Encke, A., Klinische Überprüfung des Tumormarkers CA 19-9 im Vergleich zum karzinoembryonalen Antigen (CEA) in der chirurgischen prä- und postoperativen Diagnostik, Nuklearmedizin, 1986; 25: 9–14.

    PubMed  CAS  Google Scholar 

  23. Haga, Y., Sakamoto, K., Egami, H., Yoshimura, R., Mori, K. and Akagi, M., Clinical significance of serum CA 125 values in patients with cancers of the digestive system, Am. J. Med. Sci., 1986; 292: 30–34.

    Article  PubMed  CAS  Google Scholar 

  24. Uchida, E., Steplewski, Z., Mroczek, E., Büchler, M., Burnett, D. and Pour, P.M., Presence of two distinct acinar cell populations in human pancreas based on their antigenicity. Int. J. Pancreatol., 1986; 1: 213–225.

    PubMed  CAS  Google Scholar 

  25. Uchida, E., Tempero, M.A., Burnett, D.A., Steplewski, Z. and Pour, P.M., Correlative studies on antigenicity of pancreatic cancer and blood group types of the patients, Cancer Det. Prev., in press.

  26. Atkinson, B.F., Ernst, C.S., Herlyn, M., Steplewski, Z., Sears, H.F. and Koprowski, H., Gastrointestinal cancer-associated antigen in immunoperoxidase assay, Cancer Res., 1982; 42: 4820–4823.

    PubMed  CAS  Google Scholar 

  27. Brockhaus, M., Wysocka, M., Magnani, J.L., Steplewski, Z., Koprowski, H. and Ginsburg, V., Normal salivary mucin contains the gastrointestinal cancer-associated antigen detected by monoclonal antibody 19-9 in the serum mucin of patients, Vox Sang., 1985; 48: 34–38.

    Article  PubMed  CAS  Google Scholar 

  28. Bara, J., Zabaleta, E.H., Mollicone, R., Nap, M. and Burtin, P., Distribution of GICA in normal gastrointestinal and endocervical mucosae and in mucinous ovarian cysts using antibody NS 19-9, Am. J. Clin. Pathol., 1986; 85: 152–159.

    PubMed  CAS  Google Scholar 

  29. Borowitz, M.J., Tuck, F.L., Sindelar, W.F., Fernsten, P.D. and Metzgar, R.S., Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas, J. Natl. Cancer Inst., 1984; 72: 999–1005.

    PubMed  CAS  Google Scholar 

  30. Arends, J.W., Wiggers, T., Schutte, B., Verstijnen, C., Hilgers, J., Blijham, G.H. and Bosman, F.T., Monoclonal antibody (1116 NS 19-9) defined monosialoganglioside (GICA) in colorectal carcin in relation to stage, histopathology and DNA flow cytometry, Int. J. Cancer, 1983; 32: 289–293.

    Article  PubMed  CAS  Google Scholar 

  31. Arends, J.W., Wiggers, T., Verstijnen, C., Hilgers, J. and Bosman, F.T., Gastrointestinal cancer-associated antigen (GICA) immunoreactivity in colorectal carcinoma in relation to patients survival, Int. J. Cancer, 1984; 34: 193–196.

    Article  PubMed  CAS  Google Scholar 

  32. Kalthoff, H., Kreiker, C., Schmiegel, W.-H., Greten, H. and Thiele, H.-G., Characterization of CA 19-9 bearing mucins as physiological exocrine pancreatic secretion products, Cancer Res., 1986; 46: 3605–3607.

    PubMed  CAS  Google Scholar 

  33. Lan, M.S., Bast, R.C., Jr., Colnaghi, M.I., Knapp, R.C., Colcher, D., Schlom, J. and Metzgar, R.S., Co-expression of human cancer associated epitopes on mucin molecules, Int. J. Cancer, 1987; 39: 68–72.

    Article  PubMed  CAS  Google Scholar 

  34. Mahvi, D.M., Meyers, W.C., Schmiegel, W.H. and Metzgar, R.S., The secretion of a pancreatic oncofetal antigen: DU-PAN-2 into pancreatic ductal secretions, Dig. Dis. Sic., 1986; 31: 1141.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 42nd and Dewey Ave., 68105, Omaha, NE, U.S.A.

    Hideaki Takasaki & Parviz M. Pour

  2. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, U.S.A.

    Margaret A. Tempero & David A. Burnett

  3. The First Department of Surgery, Nippon Medical School, Tokyo, Japan

    Eiji Uchida

  4. Department of Microbiology and Immunology, Duke University Medical Center, Durham, NC, U.S.A.

    Richard S. Metzgar

Authors
  1. Hideaki Takasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margaret A. Tempero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David A. Burnett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard S. Metzgar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Parviz M. Pour
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takasaki, H., Uchida, E., Tempero, M.A. et al. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue. Int J Pancreatol 2, 349–360 (1987). https://doi.org/10.1007/BF02788434

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02788434

Key words

Search

Navigation